Neurocrine Biosciences, Inc. (LON:0K6R)
London flag London · Delayed Price · Currency is GBP · Price in USD
128.20
-1.28 (-0.99%)
At close: Jul 7, 2025

Neurocrine Biosciences Revenue

Neurocrine Biosciences had revenue of $572.60M USD in the quarter ending March 31, 2025, with 11.12% growth. This brings the company's revenue in the last twelve months to $2.41B, up 21.73% year-over-year. In the year 2024, Neurocrine Biosciences had annual revenue of $2.36B with 24.81% growth.

Revenue (ttm)
$2.41B
Revenue Growth
+21.73%
P/S Ratio
5.24
Revenue / Employee
$1.34M
Employees
1,800
Market Cap
9.78B GBP

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End Revenue Change Growth
Dec 31, 2024 2.36B 468.20M 24.81%
Dec 31, 2023 1.89B 398.40M 26.76%
Dec 31, 2022 1.49B 355.20M 31.34%
Dec 31, 2021 1.13B 87.60M 8.38%
Dec 31, 2020 1.05B 257.80M 32.71%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
AstraZeneca 42.56B
GSK plc 31.53B
Haleon 11.23B
Smith & Nephew 4.64B
ConvaTec Group 1.83B
Hikma Pharmaceuticals 2.50B
HUTCHMED (China) 503.39M
Genus 671.60M
Revenue Rankings

Neurocrine Biosciences News

More News